Clinical course and prognostic factors following bone recurrence from breast cancer.
about
Mechanisms of bone metastases of breast cancerContemporary approaches for imaging skeletal metastasisRole of bone-anabolic agents in the treatment of breast cancer bone metastasesReduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]Clinical management of women with metastatic breast cancer: a descriptive study according to age group.Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.Bone Metastases: An Overview.Breast cancer evaluation by fluorescent dot detection using combined mathematical morphology and multifractal techniquesMetastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.Bone metastasis: pathogenesis and therapeutic implications.Stability of spinal bone metastases in breast cancer after radiotherapy: a retrospective analysis of 157 cases.The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsTumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer.Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organsSurvival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysisImmunohistochemical Predictors of Bone Metastases in Breast Cancer Patients.Radionuclide Therapy of Bone Metastases.Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease.Clinical nomogram to predict bone-only metastasis in patients with early breast carcinomaNovel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis.Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer.Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features.Prognostic factors for patients with bone-only metastasis in breast cancerPrognostic factors in 1,038 women with metastatic breast cancer.A prospective study of bone tumor response assessment in metastatic breast cancer.Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastasesBone metastasis risk factors in breast cancer.Treatment of painful bone metastases.A novel hyperthermia treatment for bone metastases using magnetic materials.Dose-Fractionation Schedules for Radiotherapy of Bone Metastases.Denosumab and the current status of bone-modifying drugs in breast cancer.Assessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes.Predictors of early distant metastasis in women with breast cancer.Bone and cancer: the osteoncology.Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor.Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.Bone-derived soluble factors and laminin-511 cooperate to promote migration, invasion and survival of bone-metastatic breast tumor cells.
P2860
Q24597798-9A883DEF-997E-4105-B794-190FAC4D7A60Q26798170-B20EFAB9-6A4A-414D-96C3-55496BFC34D2Q26822732-504DDEF8-D798-4AD0-BF69-AF5339E517F3Q28195767-78E06035-19F7-41D5-B880-C95CE7303BF4Q33249084-7C386019-4F3B-4893-B280-24A32DB7AAABQ33506542-3C849C50-4AC8-459E-B060-AACDBAF68AE1Q33727278-FE47B50F-D54B-4E79-B979-149913ACC808Q33871528-54346C1C-E185-4A8A-B221-E9F9B58763F1Q33903716-174810DA-4BE6-4564-8AE0-416CB5BF4AF4Q34008243-19970CE7-EACA-4A47-9042-DB94F1D047FFQ34079207-89510988-6156-4B17-A007-334C47EBF0AAQ34617864-FB1EDDAB-6AAE-4EDF-AFAC-1C8346B65BBBQ35012766-EF993B7B-E946-4EEA-A96C-8A5ADF9DD8D7Q35113022-12D71AD4-AFBB-41BE-87B1-C3E0EC5C98DFQ35202963-4EA1A175-DC4E-4306-97AE-859ACE35D0AEQ35573228-87C9165C-360A-43C9-9236-06708F95E3E2Q35584408-3C79F38A-8D0B-4D22-BF07-62A93567B096Q35998694-00755C76-15E1-4901-903E-D7F2F690FCFBQ36036136-D10077A2-0D3D-4D3E-9405-3C0C89E3D183Q36144917-04AFB22E-2EA9-4561-A378-968F79DF375FQ36295018-4A637C32-A68C-4693-8477-4228920C30CFQ36323486-97C831CA-5414-4DC2-899C-23314695A0CAQ36442668-7D0384A8-4B1D-4DA8-BFEB-2EA73C1D21B4Q36491537-7BD21402-0410-440F-9B7A-BAD919F14394Q36648280-886FE0B5-E365-4D5A-B781-0B6F523EB861Q37094622-3FCE0BB7-6DFC-4FA1-BCF6-5E963FD68CECQ37321930-127AFE3D-B718-472D-8F9F-6F09ACD9024EQ37393126-63307697-AC5F-4E01-B2BC-AF32A8D83D8DQ37483543-CA36A68B-D997-4833-8C96-E628FF96D607Q37629662-F3B62795-EC42-41ED-8187-7131E6A23891Q37710370-F45B912D-D2BF-44F6-897A-B65D9274041BQ37849622-EC6A305B-823C-4533-A3EA-546C7805C1C1Q37903673-B3D280F5-6E1C-4C74-8ACD-C13CE4AA77B3Q37965768-7CCBDAED-ED24-4593-B74E-0239FB781214Q38018675-B27C1E1D-E751-4472-90A3-685219FC693EQ38071245-69951D81-50E8-486F-BB04-21523CA01D44Q38153390-B5944CDD-6465-4757-B00E-4ADF5390E160Q38155649-B5C3C18A-639E-42E7-B862-D5C83B99EB22Q38629732-61DE02B2-9003-4487-B3E5-625F5D926123Q39018130-E39AAE1D-46D1-402E-9936-61F55A3E22F3
P2860
Clinical course and prognostic factors following bone recurrence from breast cancer.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Clinical course and prognostic factors following bone recurrence from breast cancer.
@ast
Clinical course and prognostic factors following bone recurrence from breast cancer.
@en
Clinical course and prognostic factors following bone recurrence from breast cancer.
@nl
type
label
Clinical course and prognostic factors following bone recurrence from breast cancer.
@ast
Clinical course and prognostic factors following bone recurrence from breast cancer.
@en
Clinical course and prognostic factors following bone recurrence from breast cancer.
@nl
prefLabel
Clinical course and prognostic factors following bone recurrence from breast cancer.
@ast
Clinical course and prognostic factors following bone recurrence from breast cancer.
@en
Clinical course and prognostic factors following bone recurrence from breast cancer.
@nl
P2093
P2860
P356
P1476
Clinical course and prognostic factors following bone recurrence from breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.52
P407
P577
1998-01-01T00:00:00Z
P5875
P6179
1043619477